Lifecore Biomedical, Inc. De (LFCR) Current Assets (2011 - 2025)

Lifecore Biomedical has reported Current Assets for 15 years, with the latest figure at $85.7 million in Q2 2025.

• On a quarterly basis, Current Assets rose 5.73% year-over-year to $85.7 million in Q2 2025; TTM through May 2025 was $85.7 million, a 5.73% increase from a year earlier, with the FY2025 full-year figure at $85.7 million, up 5.73% from the prior year.
• Current Assets was $85.7 million for Q2 2025 at Lifecore Biomedical, up from $84.2 million in the prior quarter.
• The five-year high for Current Assets was $158.3 million in Q1 2021, with the low at $74.2 million in Q3 2024.
• Average Current Assets over 5 years is $104.7 million, with a median of $89.8 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Current Assets sank 35.58% in 2023, then rose 10.58% in 2025.
• Over 5 years, Current Assets stood at $150.6 million in 2021, then dropped by 20.9% to $119.1 million in 2022, then tumbled by 35.58% to $76.7 million in 2023, then increased by 6.71% to $81.9 million in 2024, then increased by 4.67% to $85.7 million in 2025.
• The last three Current Assets figures came in at $85.7 million (Q2 2025), $84.2 million (Q1 2025), and $81.9 million (Q4 2024), per Business Quant data.